Home > News > Pharmaceutical industry looks to commercial metathesis 13th February 2007
February 13th, 2007
Pharmaceutical industry looks to commercial metathesis 13th February 2007
Abstract:
Commercially available metathesis catalysts could provide drugs manufacturers with new opportunities.
Olefin metathesis is one of the most versatile ways of making carbon-carbon bonds and the process has been exploited by petrochemical, polymer, and specialty chemical industries to process simple hydrocarbons for almost 50 years.
China is expected to drive the global nanotechnology and catalysts market this year, a new report claims. Research firm RNCOS predicts that nanoscience will gain huge investment over the next twenty years, bringing about radical changes in the pharmaceutical industry.
Source:
platinum.matthey.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||